[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pavmed Inc 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 USA

www.pavmed.com Employees: 41 P: 917-813-1828

Sector:

Medical

Description:

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 4,719
Enterprise Value, $K 27,859
Shares Outstanding, K 996
Float, K 862
% Float 86.60%
Short Interest, K 27
Short Float 2.74%
Days to Cover 2.18
Short Volume Ratio 0.60
% of Insider Shareholders 13.40%
% of Institutional Shareholders 19.93%

Financials:

Annual Sales, $ 70 K
Annual Net Income, $ 400 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -60 K
EBIT, $ -24,400 K
EBITDA, $ -24,290 K

Growth:

1-Year Return -65.35%
3-Year Return -96.59%
5-Year Return -99.83%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.17 on 05/15/26
Next Earnings Date 08/14/26 [BMO]
Earnings Per Share ttm -16.29
EPS Growth vs. Prev Qtr -241.22%
EPS Growth vs. Prev Year -6.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 01/02/26

PAVM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -146.19%
Return-on-Assets % -18.39%
Profit Margin % 571.43%
Debt/Equity 0.60
Price/Sales 69.28
Price/Cash Flow N/A
Price/Book 0.23
Book Value/Share 24.99
Interest Coverage -122.50
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.